Family Practice News Digital NetworkHeart of a Lion: Rheumatologist Holds Fast to His Charitable PlansFamily Practice News Digital NetworkDr. Lee's undertaking is inspired by his beloved aunt, Maureen Rayner, of Bournemouth in the south of England,…
Onyx: Deal Or No Deal, Time For A Payoff – Seeking Alpha
Onyx: Deal Or No Deal, Time For A PayoffSeeking AlphaThe study included patients who were eligible for a stem cell transplant. It was interesting to learn that these patients were able to remain on the Carflizomib combination and achieve responses simi…
Secondhand smoke tied to bad heart failure outcomes – Reuters
Secondhand smoke tied to bad heart failure outcomesReutersNEW YORK (Reuters Health) – If you have chronic heart failure, being around a smoker may be bad for your physical and mental well-being, a new study suggests. Researchers found that of 205 non-s…
Everolimus prolongs progression-free survival for patients with neuroendocrine … – EurekAlert (press release)
Everolimus prolongs progression-free survival for patients with neuroendocrine …EurekAlert (press release)HOUSTON — Combination treatment with everolimus, an inhibitor of the mammalian target rapamycin (mTOR), and octreotide has shown to improve pro…
Increasing organ donation a health care priority – Nova News Now
Nova News NowIncreasing organ donation a health care priorityNova News NowHe said increasing awareness of organ donation is one small way people can get involved and help make some positive changes. “As Canadians, we need to work much harder on organ…
Perth researcher leads trial into AIDS vaccine – The West Australian
The West AustralianPerth researcher leads trial into AIDS vaccineThe West AustralianDr D'Orsogna, 35, won a European medical prize for his recent work in the Netherlands studying organ transplant rejection. He showed immune responses against transp…
Intensified Immunochemotherapy Benefits B-Cell Lymphoma – Doctors Lounge
ecancermedicalscienceIntensified Immunochemotherapy Benefits B-Cell LymphomaDoctors LoungeFor patients with untreated diffuse large B-cell lymphoma, intensified immunochemotherapy with rituximab, doxorubicin, cyclophosphamide, vindesine, bleomycin, and…
TBI: Not a Single Disease, but Many – Family Practice News Digital Network
Family Practice News Digital NetworkTBI: Not a Single Disease, but ManyFamily Practice News Digital NetworkDiffuse cerebral swelling, the most common cause of brain death following severe TBI in both adults and children, is 3.5 times more common in chi…
Intense Chemo Best for Aggressive Lymphoma – Medscape
ecancermedicalscienceIntense Chemo Best for Aggressive LymphomaMedscapeNovember 29, 2011 — Adding rituximab to a dose-intensive immunochemotherapy regimen significantly improves survival in young patients with diffuse large B cell lymphoma with low-i…
Bristol-Myers Squibb (BMY) Breaks Through Resistance at $31.30 – Financial News Network Online
Bristol-Myers Squibb (BMY) Breaks Through Resistance at $31.30Financial News Network OnlineThe Company's products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant reject…